New and updated respiratory syncytial virus (RSV) resources

August 13, 2025

The Australian Government Department of Health, Disability and Aging (the department) has released a number of updated resources to support the correct administration of RSV vaccines and monoclonal antibodies.

A single dose of the RSV vaccine, Abrysvo®, is recommended for women at 28 to 36 weeks of pregnancy and is available for free through the National Immunisation Program (NIP).

  • Arexvy® must not be administered to pregnant women.
  • Victoria is offering the RSV monoclonal antibody, Beyfortus™ (Nirsevimab) for free to eligible infants and children.
  • Abrysvo® and Arexvy® must not be administered to infants or children.
  • The department has produced a poster outlining the correct administration of RSV vaccines and monoclonal antibodies by cohort.

Updated resources include:

For more information visit - Respiratory syncytial virus (RSV) vaccine | Australian Government Department of Health, Disability and Ageing

Latest news

August 12, 2026
Throughout July and August, all Australians aged 50 will receive a letter about reducing their dementia risk. Some patients may bring the letter or a dementia risk assessment report to appointments to ask questions or seek support.
August 7, 2026
The purpose of this activity is to ensure patients with a mental health diagnosis (particularly high-risk mental health patients, e.g. bipolar disorder and a Mental Health Treatment Plan) that require phone (level C or D) and/or videoconference longer appointments (level C, D or E) are identified and proactively offered MyMedicare registration supporting continuity of care and improved outcomes.
August 5, 2026
Are you a First Nations carer supporting a loved one affected by alcohol, other drugs, or mental health challenges? Join Windana’s free monthly First Peoples’ Carers Program, funded by SEMPHN, and connect with others in a safe and supportive space.